(SSNC) SS&C Technologies Holdings - Ratings and Ratios
Portfolio, Trading, Healthcare, Reconciliation, Consulting
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.22% |
| Yield on Cost 5y | 1.66% |
| Yield CAGR 5y | 11.21% |
| Payout Consistency | 100.0% |
| Payout Ratio | 22.1% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 24.5% |
| Value at Risk 5%th | 38.8% |
| Relative Tail Risk | -3.79% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.58 |
| Alpha | -2.02 |
| CAGR/Max DD | 0.73 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.411 |
| Beta | 0.813 |
| Beta Downside | 0.981 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.72% |
| Mean DD | 6.02% |
| Median DD | 4.34% |
Description: SSNC SS&C Technologies Holdings December 19, 2025
SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) delivers a vertically integrated suite of software and software-enabled services to the financial services and healthcare sectors, covering the full workflow from front-office trading and modeling through middle-office portfolio management to back-office accounting, compliance, and clearing, as well as claims adjudication and care-management tools for health providers.
In FY 2023 the company reported revenue of roughly $6.5 billion, a year-over-year increase of about 8%, driven by strong growth in its SaaS-based investment-management platform (ARR now exceeds $5.5 billion). The client base exceeds 8,000 institutions, and operating margins have improved to ~14% as the firm scales its managed services and data-solution offerings. A key sector driver is the accelerating migration of asset managers to cloud-native, low-latency trading and compliance suites, which is bolstered by regulatory pressure for real-time reporting and by fee-compression trends that favor cost-efficient technology partners.
For a deeper quantitative view, the ValueRay platform offers granular financial metrics and peer comparisons worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (852.0m TTM) > 0 and > 6% of Revenue (6% = 368.9m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 2.75pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 9.02% (prev 11.64%; Δ -2.62pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 1.56b > Net Income 852.0m (YES >=105%, WARN >=100%) |
| Net Debt (6.42b) to EBITDA (2.13b) ratio: 3.01 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.12 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (253.1m) change vs 12m ago -0.39% (target <= -2.0% for YES) |
| Gross Margin 48.56% (prev 49.08%; Δ -0.52pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 32.42% (prev 31.26%; Δ 1.16pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.27 (EBITDA TTM 2.13b / Interest Expense TTM 439.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.69
| (A) 0.03 = (Total Current Assets 5.32b - Total Current Liabilities 4.77b) / Total Assets 19.49b |
| (B) 0.21 = Retained Earnings (Balance) 4.05b / Total Assets 19.49b |
| (C) 0.08 = EBIT TTM 1.43b / Avg Total Assets 18.96b |
| (D) 0.30 = Book Value of Equity 3.75b / Total Liabilities 12.50b |
| Total Rating: 1.69 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 70.36
| 1. Piotroski 5.50pt |
| 2. FCF Yield 5.79% |
| 3. FCF Margin 26.40% |
| 4. Debt/Equity 0.98 |
| 5. Debt/Ebitda 3.01 |
| 6. ROIC - WACC (= 1.65)% |
| 7. RoE 12.54% |
| 8. Rev. Trend 98.48% |
| 9. EPS Trend -7.54% |
What is the price of SSNC shares?
Over the past week, the price has changed by -2.54%, over one month by -1.20%, over three months by +6.37% and over the past year by +15.17%.
Is SSNC a buy, sell or hold?
- Strong Buy: 6
- Buy: 4
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SSNC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 100.4 | 16.9% |
| Analysts Target Price | 100.4 | 16.9% |
| ValueRay Target Price | 93.2 | 8.4% |
SSNC Fundamental Data Overview January 09, 2026
P/E Forward = 13.4771
P/S = 3.5125
P/B = 3.1225
P/EG = 0.9911
Beta = 1.195
Revenue TTM = 6.15b USD
EBIT TTM = 1.43b USD
EBITDA TTM = 2.13b USD
Long Term Debt = 6.57b USD (from longTermDebt, last quarter)
Short Term Debt = 20.0m USD (from shortTermDebt, last quarter)
Debt = 6.81b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.42b USD (from netDebt column, last quarter)
Enterprise Value = 28.01b USD (21.60b + Debt 6.81b - CCE 388.3m)
Interest Coverage Ratio = 3.27 (Ebit TTM 1.43b / Interest Expense TTM 439.0m)
EV/FCF = 17.26x (Enterprise Value 28.01b / FCF TTM 1.62b)
FCF Yield = 5.79% (FCF TTM 1.62b / Enterprise Value 28.01b)
FCF Margin = 26.40% (FCF TTM 1.62b / Revenue TTM 6.15b)
Net Margin = 13.86% (Net Income TTM 852.0m / Revenue TTM 6.15b)
Gross Margin = 48.56% ((Revenue TTM 6.15b - Cost of Revenue TTM 3.16b) / Revenue TTM)
Gross Margin QoQ = 47.69% (prev 47.95%)
Tobins Q-Ratio = 1.44 (Enterprise Value 28.01b / Total Assets 19.49b)
Interest Expense / Debt = 1.53% (Interest Expense 104.2m / Debt 6.81b)
Taxrate = 17.13% (43.5m / 253.9m)
NOPAT = 1.19b (EBIT 1.43b * (1 - 17.13%))
Current Ratio = 1.12 (Total Current Assets 5.32b / Total Current Liabilities 4.77b)
Debt / Equity = 0.98 (Debt 6.81b / totalStockholderEquity, last quarter 6.93b)
Debt / EBITDA = 3.01 (Net Debt 6.42b / EBITDA 2.13b)
Debt / FCF = 3.95 (Net Debt 6.42b / FCF TTM 1.62b)
Total Stockholder Equity = 6.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.49% (Net Income 852.0m / Total Assets 19.49b)
RoE = 12.54% (Net Income TTM 852.0m / Total Stockholder Equity 6.80b)
RoCE = 10.72% (EBIT 1.43b / Capital Employed (Equity 6.80b + L.T.Debt 6.57b))
RoIC = 8.72% (NOPAT 1.19b / Invested Capital 13.62b)
WACC = 7.08% (E(21.60b)/V(28.40b) * Re(8.91%) + D(6.81b)/V(28.40b) * Rd(1.53%) * (1-Tc(0.17)))
Discount Rate = 8.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.20%
[DCF Debug] Terminal Value 81.47% ; FCFF base≈1.39b ; Y1≈1.37b ; Y5≈1.43b
Fair Price DCF = 99.09 (EV 30.60b - Net Debt 6.42b = Equity 24.18b / Shares 244.0m; r=7.08% [WACC]; 5y FCF grow -1.72% → 2.90% )
EPS Correlation: -7.54 | EPS CAGR: 5.60% | SUE: 1.15 | # QB: 1
Revenue Correlation: 98.48 | Revenue CAGR: 5.25% | SUE: 1.02 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.63 | Chg30d=+0.040 | Revisions Net=+5 | Analysts=7
EPS next Year (2026-12-31): EPS=6.63 | Chg30d=-0.010 | Revisions Net=-1 | Growth EPS=+9.3% | Growth Revenue=+5.9%
Additional Sources for SSNC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle